RADLogics company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Founded Year



Acq - Fin | Alive

About RADLogics

RADLogics is a healthcare software company offering an AI image analysis platform and applications supporting imaging data associated with CTs, MRIs, PET-CTs, and X-rays, to improve radiologists' productivity while enhancing patient outcomes. In addition to largest set of AI algorithms, the RADLogics cloud-based Virtual-Resident(tm) solution provides full integration with radiologists existing workflow environment.

RADLogics Headquarter Location

11 Times Square Floor 37

New York, New York, 10036,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RADLogics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RADLogics is included in 5 Expert Collections, including Artificial Intelligence.


Artificial Intelligence

8,717 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Digital Health

12,814 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

2,606 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.


Medical Devices

3,286 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)


Health Monitoring & Diagnostics

313 items

Companies developing technology for computer-aided diagnostic imaging. Companies tagged as #ComputerAidedDxImaging

RADLogics Patents

RADLogics has filed 3 patents.

patents chart

Application Date

Grant Date


Related Topics




Medical imaging, Health informatics, Image processing, Radiology, Telehealth


Application Date


Grant Date



Related Topics

Medical imaging, Health informatics, Image processing, Radiology, Telehealth



Latest RADLogics News

Large-Scale Multi-Medical Center Study Finds AI-Powered COVID-19 Solution by RADLogics Reduces Report Turnaround Time by 30 Percent

Mar 15, 2021

Share The Moscow Center for Diagnostics & Telemedicine presented clinical research findings during ECR 2021 highlighting that full integration of AI into radiology workflow during the pandemic increased radiologists’ productivity by saving an average of 7 minutes per radiology report RADLogics and the Moscow Center for Diagnostics & Telemedicine shared the results of a large-scale study conducted by the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department. The clinical research found that the introduction of RADLogics’ AI-Powered solution into radiology workflow to analyze Chest-CT scans during the COVID-19 pandemic reduced report turnaround time by an average of 30 percent, which is equivalent to 7 minutes per case. Presented by Dr. Tatiana Logunova, MD, of the Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department during the recent ECR 2021 conference, the extensive research included a total of 128,350 Chest-CT scans, of which 36,358 were processed by RADLogics AI-Powered COVID-19 solution, reported by 570 participating radiologists at over 130 hospitals and outpatient clinics in Moscow. “Early on in the pandemic, it was clear to us that COVID-19 required new healthcare management approaches, and effective clinical management depends more on disease severity than on the virus identification,” said Dr. Sergey Morozov, MD, PhD, MPH, who serves as CEO of Moscow Diagnostics and Telemedicine Center. “As a result, the aim of our research was to determine the impact of the introduction of AI-services analyzing Chest-CTs for COVID-19 related findings on the radiologists’ workflow and performance. In addition to finding that the integration of AI did not have a negative effect on the interpretation or report accuracy, our researchers found a significant improvement in productivity and report turnaround time by the expert radiologists that leveraged AI.” Related Posts The study was conducted over two separate phases with the first taking place between April 30, 2020 to June 18, 2020 and the second taking place between June 18, 2020 to August 31, 2020. The study found that report turnaround time was significantly shorter for all time periods in a group of radiologists with available AI results that were seamlessly integrated into radiologists’ current workflow, compared to a group with non-available AI results. In addition, in the shift between the two study time periods, additional clinical parameters were added to the standard of care, including the addition of a disease severity score. The added information created an increased workload on radiologists, which increased the average read time by more than 25 percent. In response, the RADLogics AI-Powered COVID-19 solution was enhanced to support the new clinical requirements. Results shown indicate that with the augmented AI solution, including all clinical measurements and severity scoring, was able to maintain the overall productivity gain of 30 percent. “We applaud this significant real-world research by Dr. Morozov and his team, who were on the frontline of Moscow’s successful fight against the COVID-19 pandemic while demonstrating the value of embracing new AI technologies to aid in these efforts,” said Moshe Becker , CEO and Co-Founder of RADLogics. “This study – first of its kind in its scale – demonstrates the full potential of AI as a tool to augment radiologists to increase throughput, improve efficiency and reduce time-to-treatment. This research provides large-scale clinical validation to an earlier academic study by UCLA that was published in Academic Radiology, which conducted a time-motion study using our AI-powered solution to measure the impact of our solution on radiologists’ productivity that found out using our solution saved up to 44 percent in radiologists’ reading time.” Since the start of the pandemic, RADLogics has responded with the deployment of the company’s AI-Powered medical image analysis solution worldwide. Designed for easy installation and integration both on-site and via the cloud, RADLogics’ algorithms are supported by the company’s patented software platform that enables rapid deployment at multiple hospitals, and seamless integration with existing workflows. In accordance with FDA guidance for imaging systems and software to address the COVID-19 public health emergency, RADLogics has made its FDA cleared CT and X-ray solutions available to hospitals and healthcare systems throughout the U.S. for patient triage and management. All the company’s AI-Powered solutions are available worldwide through major OEM distribution partners including Nuance via the AI Marketplace in the U.S. market. “In addition to the sheer scale of this research, it is important to note the demonstrated ability of our AI-powered solution to quickly adapt to the change in clinical requirements and maintain the overall performance as demonstrated in the second phase of the study,” added Becker. “In the near-term, responsive and scalable AI algorithms could play a critical role as healthcare systems across the world contend with potential coronavirus surges as new variants spread – not to mention the tremendous burnout and economic pressures across the healthcare sector. In the long-term, this groundbreaking research also illustrates the tremendous benefit of adopting robust AI platforms that can be deployed rapidly at scale and seamlessly integrated into existing workflows to augment radiology teams.”

  • When was RADLogics founded?

    RADLogics was founded in 2010.

  • Where is RADLogics's headquarters?

    RADLogics's headquarters is located at 11 Times Square, New York.

  • What is RADLogics's latest funding round?

    RADLogics's latest funding round is Acq - Fin.

  • Who are the investors of RADLogics?

    Investors of RADLogics include Tianjin Dazhen Asset Management and East Ocean Ventures.

  • Who are RADLogics's competitors?

    Competitors of RADLogics include Enspectra Health and 5 more.

You May Also Like

Kheiron Medical Technologies

Kheiron Medical Technologies is a healthcare software company. Through its Machine Learning technology, it seeks to makes cancer diagnoses faster, easier, cheaper and more accurate. Its Deep Learning algorithms analyze medical images and its software uses the analysis results to enable the automation of radiology reporting tasks.

Ultromics Logo

Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

Aidoc Medical

Aidoc finds and flags critical findings in medical images. By automatically prioritizing urgent, life-threatening conditions like intracranial hemorrhage and pulmonary embolism, Aidoc saves lives, improves patient care and cuts waiting time for the must urgent patients down to only a few minutes. The always-on AI integrates into a radiologist's workflow, reprioritizing cases without forcing radiologists to change the way they work.

InformAI Logo

InformAI is a healthcare technology company focused on AI/deep learning and business analytics solutions for hospital groups, medical device companies, and payer organizations. Specific AI solutions include medical image classification, healthcare operational, and patient outcomes prediction algorithms.

Qure.ai Logo

Qure.ai has developed an artificial intelligence-based system to identify abnormalities in head CT scans. The company aims to leverage deep learning effectively to diagnose diseases from radiology and pathology imaging and create personalized cancer treatment plans from psychopathology imaging and genome sequences. It was founded in 2016 and is based in Mumbai, India.

Infervision Logo

Infervision is a global high-tech enterprise in medical artificial intelligence, aiming to empower doctors with higher efficiency and benefit patients with better diagnosis, outcome, and lower cost. Infervision provides products and services to providers, and patients; with robust A.I. solutions fully integrated with the healthcare workflow to help diagnosing various diseases and conditions such as cerebral hemorrhage, lung cancer, bone fractures, emphysema, and more. Infervision also provides an AI-powered research platform for medical professionals with any research directions and needs.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.